Mallinckrodt Wants More Cuts To Seizure Drug Price Suit

By Julia Arciga · May 26, 2020, 4:20 PM EDT

Mallinckrodt has asked a California federal judge to cut more antitrust claims from Humana's $700 million price-gouging lawsuit over an infant seizure syndrome treatment, claiming the insurer yet again defined the...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Motion

Case Information

Case Title

Humana, Inc. v. Mallinckrodt ARD LLC et al

Case Number

Court

California Central

Nature of Suit

Anti-Trust

Date Filed

August 08, 2019

Recent Articles By Julia

February 19, 2021
EU Clears Varian's $16.4B Sale To Siemens Unit With Fixes
February 04, 2021
Ambulance Co. Wants Full 4th Circ. To Revive Antitrust Case
January 28, 2021
9th Circ. Urged To Toss SmileDirect Harassment Suit
January 11, 2021
Becton Buyers Defend Revived Antitrust Suit
January 08, 2021
Shkreli Can't Pause Suit Pending Prison Release, Judge Says
January 07, 2021
Insurers Urge Court To Preserve Cancer Drug Antitrust Suit
January 05, 2021
Health Care Co. Appeals Contract Terminations To 6th Circ.
December 16, 2020
DEA Urges Court To Drop Whistleblower's Discrimination Case
December 10, 2020
Health Care Staffing Co. Ex-Owner Charged With Wage-Fixing
December 03, 2020
Dueling Attys Call For Xyrem MDL To Be Moved To CA Or NJ